|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
Abstract |
|---|
|
|
|---|
Epithelial-mesenchymal interactions mediate prenatal lung morphogenesis and differentiation, yet little is known about their effects in the adult. In this study we have examined the influence of cocultured lung fibroblasts on rat alveolar type II cell
differentiation in primary culture. Type II cells that were co-cultured with lung fibroblasts showed significant increases in
messenger RNA (mRNA) levels of surfactant protein (SP)-A,
SP-B, SP-C, and SP-D. Metabolic labeling and immunohistochemistry demonstrated that these mRNAs were translated and
processed. Addition of 10
7 M dexamethasone (DEX) to cocultures antagonized the effects of the fibroblasts on SP-A and
SP-C, but significantly augmented the effects on SP-B; expression of SP-D was unaffected. Coculture of type II cells with
lung fibroblasts also increased acetate incorporation into phospholipids 10-fold, which was antagonized by DEX. Keratinocyte
growth factor (KGF) mimicked the effects of lung fibroblasts
on SP gene expression, but KGF neutralizing antibodies only
partially reduced the effects of lung fibroblasts. KGF increased
acetate incorporation into surfactant phospholipids, and the
addition of DEX augmented this response. Together, our observations suggest that epithelial-mesenchymal interactions affect type II cell differentiation in the adult lung, and that these
effects are partially mediated by KGF.
| |
Introduction |
|---|
|
|
|---|
The synthesis and secretion of pulmonary surfactant, which is a complex of phospholipids and the lung-specific surfactant proteins (SPs) SP-A, SP-B, and SP-C, is a primary function of alveolar type II cells. The elucidation of the mechanisms regulating surfactant production is of great interest because insufficiency of pulmonary surfactant leads to respiratory distress, and abnormalities in its composition are associated with a number of lung diseases. Because the lung is composed of many different cell types, studies on the regulation of type II cell differentiated function have often been carried out on cultures of purified type II cells. A consistent observation in these studies has been that type II cells maintained on a tissue culture plastic substratum rapidly lose markers of differentiated function. A number of laboratories have attempted to sustain adult type II cell differentiation by culturing cells on biologic substrata, with varying degrees of success (1). Previous studies in our laboratory have shown that type II cells cultured in association with fetal rat lung fibroblasts on floating collagen gels, or on a reconstituted basement membrane gel derived from the Engelbreth-Holm-Swarm tumor, exhibit significantly improved maintenance of type II cell morphology, patterns of phospholipid biosynthesis, and expression of messenger RNAs (mRNAs) for SP-A, SP-B, and SP-C (2, 3). We have attributed the improvement in type II cell function in these culture systems to the re-establishment of requisite cell-extracellular matrix (ECM) interactions and maintenance of native type II cuboidal cell shape (4). Our previous studies also suggested that epithelial-mesenchymal interactions, which have been shown to be absolutely required for prenatal lung growth and differentiation, also had a positive influence on adult type II cell differentiation (2). In the present study we have developed a culture system that allowed us to directly examine the contribution of lung fibroblasts to adult type II cell differentiation. The results show that the presence of lung fibroblasts has a significant impact on the ability of type II cells to synthesize SPs and phospholipids, which is mediated in part by keratinocyte growth factor (KGF, also known as fibroblast growth factor [FGF]-7).
| |
Materials and Methods |
|---|
|
|
|---|
Materials
Matrigel was obtained from Collaborative Biomedical Products (Bedford, MA). Human recombinant KGF (or FGF-7) was obtained from Promega Biotech (Madison, WI). Neutralizing antibodies to human KGF were purchased from R&D Systems (Minneapolis, MN). Dexamethasone (DEX), forskolin (FSK), and 3-isobutyl-1-methylxanthine (IBMX) were obtained from Sigma Chemical (St. Louis, MO). Preparation of the rabbit polyclonal antibodies against rat SP-A (5) and rat SP-D (6) have been previously described and were provided by Dr. D. Voelker (National Jewish Medical and Research Center, Denver, CO). Rabbit polyclonal antibodies against mature bovine SP-B (#28031), human pro-SP-B (#96819), and human pro-SP-C (#R68514) were generously provided by Drs. J. Whitsett and T. Weaver (Children's Hospital Medical Center, Cincinnati, OH).
Isolation of Type II Cells
Type II cells were dissociated from the lungs of specific pathogen-free adult male Sprague-Dawley rats (Harlan, Indianapolis, IN) with porcine pancreatic elastase (Worthington Biochemicals, Freehold, NJ) and purified on discontinuous metrizamide gradients as previously described (7). Purified type II cells were resuspended in Dulbecco's modified Eagle's medium (DMEM) (GIBCO BRL, Gaithersburg, MD) containing 1% charcoal-stripped fetal (8) bovine serum (CSFBS) (Gemini Bio-Products, Calabasas, CA), 100 U/ml penicillin, 100 µg/ml streptomycin, 2.5 µg/ml amphotericin B (all from GIBCO BRL), and 10 µg/ml gentamicin sulfate (Sigma), and plated into the wells of six-well cluster dishes (Becton Dickinson, Lincoln Park, NJ) coated with 1 ml of Matrigel that had been diluted with DMEM (1:2, DMEM/Matrigel). Type II cells were seeded into each well at a density of 5 × 105 viable cells/cm2; the day of isolation was considered Day 0 of culture.
Preparation of Fibroblast/Collagen Rafts
Lung fibroblasts isolated from Day 19 rat fetuses and from adult rats were prepared as previously described (2, 4) and used between passages 4-15. Adult human lung fibroblasts (HLF) (Repository #AG02262; Coriell Institute for Medical Research, Camden, NJ) were used between passages 3 and 6. Fibroblasts were resuspended in a small volume (approximately 250 µl) of DMEM, then mixed with neutralized rat-tail collagen solution that was prepared on ice as previously described (2), with the exception that 10× Waymouth's 752/1 medium was used for the neutralization solution. Unless otherwise noted, the final concentration of fibroblasts was 3.3 × 106 cells/ml collagen. A total of 300 µl of collagen solution containing fibroblasts was carefully spread on the surface of a 25-mm-diameter, 0.8-µm-pore-size nucleopore filter (Costar, Corning, NY) and gelled at 37°C.
Preparation of Cocultures
Medium in the type II cell cultures was changed on Day 1 to remove nonadherent cells, and then a fibroblast/collagen raft was carefully transferred to each well with forceps. The hydrophobic nature of the polycarbonate filters caused the fibroblast/collagen rafts to float at or near the surface of the culture medium. Molecules secreted by the fibroblasts could therefore freely diffuse into the medium, but the physical separation of the type II cells and fibroblasts allowed us to analyze only the type II cells. Control cultures consisted of type II cells cultured with collagen rafts containing no fibroblasts, or type II cells cultured by themselves.
KGF Neutralization Experiments
To determine whether the observed effects of cocultured fibroblasts were due to the presence of KGF, antibody neutralization experiments were performed. Type II cells were isolated and plated as previously described, then cultured for 24 h. Rafts containing 1 × 106 HLF were then added to the cultures, along with 10 µg/ml antihuman KGF (R&D Systems). A second group of cocultures received vehicle (phosphate-buffered saline [PBS]) only. As controls for the efficacy of the antibody, a third set of cultures was treated with 1 ng/ml human KGF, and a fourth set of cultures was treated with 1 ng/ml human KGF plus 10 µg/ml antihuman KGF. A final set of cultures was treated with 10 µg/ml antihuman KGF alone. Cultures were maintained for an additional 24 h, at which point the cells were harvested for RNA isolation and determination of SP mRNA content.
Preparation of RNA and Northern Blots
Type II cells on Matrigel were directly lysed into 4 M guanidinium
isothiocyanate, 0.5% N-laurylsarcosine, and 0.1 M
-mercaptoethanol in 25 mM sodium citrate buffer. Lysis was monitored visually to ensure that a minimum of Matrigel was solubilized into the
lysate. Total cellular RNA was isolated by centrifugation through a
5.7 M CsCl cushion at 150,000 × g for 18 h. Northern blots were
prepared and probed with complementary DNAs (cDNAs) for
rat SP-A, SP-B, SP-C, and SP-D that had been radiolabeled to
high specific activity with [
-32P]deoxycytidine triphosphate (dCTP)
(ICN Pharmaceuticals, Costa Mesa, CA) by random-primed second-strand synthesis using a commercially available kit (GIBCO
BRL). Hybridization and washing of blots were performed as previously described (3). Direct quantitation of radioactive counts on
blots was performed using Molecular Dynamics ImageQuant software, version 3.22 (Molecular Dynamics, Sunnyvale, CA).
Ribonuclease Protection Assays
In some experiments, total RNA isolated from elutriated type II cells was analyzed for SP mRNA expression using a ribonuclease protection assay (RPA) that allowed simultaneous measurement of mRNAs for SP-A, SP-B, SP-C, and SP-D. Fragments of different sizes for the four SPs were isolated by polymerase chain reaction using full-length cDNAs as templates. The forward primers included a BamH1 restriction site added to the 5' end and the backward primers included an EcoR1 restriction site added to the 5' end to facilitate directional cloning into pGEM 4Z (Promega). The primers for SP-A were 5'-CGGATCCAGTCCTCAGCTTGCAAGGATC-3', coding sense and corresponding to nucleotides 424-444; and 5'-GGAATTCCGTTCTCCTCAGGAGTCCTCG-3', coding antisense and corresponding to nucleotides 549-569. The probe transcribed from this clone identified a fragment of 146 base pairs (bp). The primers for SP-B were 5'-CGGATCCGAGCAGTTTGTGGAACAGCAC-3', coding sense and corresponding to nucleotides 997-1017; and 5'-GGAATTCTGGTCCTTTGGTACAGGTTGC-3', coding antisense and corresponding to nucleotides 1152-1172. The probe transcribed from this clone identified a fragment of 176 bp. The primers for SP-C were 5'-CGGATCCCATACTGAGATGGTCCTTGAG-3', coding sense and corresponding to nucleotides 202-222; and 5'-GGAATTCTCTGGAGCCATCTTCATGATG-3', coding antisense and corresponding to nucleotides 381-401. The probe transcribed from this clone identified a fragment of 200 bp. The primers for SP-D were 5'-CGGATCCCGGAAGAGCCTTTTGAGGATG-3', coding sense and corresponding to nucleotides 831-851; and 5'-GGAATTCACAGTTCTCTGCCCCTCCATTG-3', coding antisense and corresponding to nucleotides 1054-1075. The probe transcribed from this clone identified a fragment of 245 bp.
The vectors were linearized with BamH1 and radiolabeled antisense probes were transcribed in vitro using a commercially
available kit (Promega) and [
-32P]CTP (800 Ci/mmol; ICN). The
RNA probe was purified on an 8% polyacrylamide/7 M urea gel
and eluted from the most intense band detected by autoradiography. An 18S ribosomal RNA (rRNA) probe, which was synthesized using pT7 RNA 18S template and the T7 MEGAshortscript Kit (Ambion, Austin, TX) and [
-32P]CTP, was used as an internal standard for RNA quantitation. The amount of 2 to 5 µg of
total cellular RNA was hybridized at 45°C for 24 h with 1 × 105
counts/min (cpm) of antisense probe. Probe not protected by hybridization with target RNA was digested with a mixture of
RNase A and T1 (RPAII kit; Ambion). The protected RNA duplex fragments were precipitated, resuspended, and separated
on an 8% polyacrylamide/7 M urea gel. The gel was dried and exposed to Hyperfilm (Amersham Life Science Products, Arlington
Heights, IL) at
70°C. Radioactive counts were obtained from
protected fragments for SP-A, SP-B, SP-C, and SP-D by ImageQuant analysis and normalized to 18S rRNA. This assay gives
linear results from inputs of 1 to at least 15 µg of total RNA.
Metabolic Labeling and Immunoprecipitation of SP
On Day 4 of culture, the medium and the fibroblast/collagen rafts were removed from the cultures and replaced with 2 ml of cysteine-methionine-free DMEM (ICN) plus 1% CSFBS and incubated for 30 min. This medium was then replaced with 0.5 ml of fresh medium containing 1 mCi/ml of TRAN35S-Label (ICN; specific activity > 1,000 Ci/mmol). After 4 h of metabolic labeling, the cells were removed from the Matrigel with dispase; washed twice with PBS (pH 7.4); then lysed into 190 mM NaCl, 60 mM Tris (pH 7.4), 6 mM ethylenediaminetetraacetic acid, 4% sodium dodecyl sulfate containing 1 mM phenylmethylsulfonyl fluoride, 5 mM N-ethylmaleimide, and 10 µg/ml pepstatin A (all from Sigma). Immunoprecipitation of radiolabeled proteins was then performed as described elsewhere (9) and autoradiograms were prepared. Rabbit polyclonal antibodies against rat SP-A, rat SP-D, human pro-SP-C, and bovine SP-B (antibody #28031) were used for immunoprecipitation.
Immunohistochemistry
For immunohistochemistry, type II cells were first released from the Matrigel by incubation in dispase for 1 h at 37°C. Cell aggregates were pelleted by centrifugation at 150 × g, resuspended in PBS, and recentrifuged. The pelleted aggregates were then resuspended in 250 µl of cold neutralized rat-tail collagen solution. This suspension was transferred to a small piece of Parafilm and allowed to gel at 37°C. The gel was then fixed in freshly prepared 4% paraformaldehyde in PBS and embedded in paraffin. This collagen-enrobing procedure allowed us to evaluate cross sections of many aggregates in one section. Sections 4 µm thick were immunostained with polyclonal antibodies against rat SP-A, human pro-SP-B (antibody #96819), and human pro-SP-C using standard avidin-biotin complex techniques (6). Sections that were immunostained for SP-A were subjected to antigen retrieval using 6 N guanidinium hydrochloride and 0.2 mg/ml trypsin as previously described (6).
Labeling and Analysis of Lipids
The pattern and quantity of lipid synthesis by type II cells cultured under the various conditions was performed as described previously (2). Briefly, on Day 3 of culture the cells were incubated with 10 µCi/ml [1-14C]acetate (ICN; sp. act. 25-60 µCi/ mmol) for the final 24 h before harvesting. Lipids were extracted with methanol and chloroform, then separated by two-dimensional thin layer chromatography on DC-Fertigplatten Kieselgel 60 plates (E. Merck, Darmstadt, Germany). Individual phospholipid spots were scraped directly into scintillation vials, their incorporated radioactivity was determined, then the incorporation of acetate into each phospholipid species as a percentage of total phospholipids was determined. The percentage of saturated phosphatidylcholine (PC) was determined by the method of Mason and Nellenbogen (10). We also determined the amount of radiolabeled acetate incorporated into neutral lipids. Because some of the treatments might result in cell proliferation, the relative amount of lipid synthesis was normalized to DNA content. Therefore, parallel cultures of each condition were prepared in triplicate. On the day of harvest, the type II cells were removed from the Matrigel substratum by incubation in dispase for 1 h at 37°C and pelleted by centrifugation, then DNA content was determined fluorimetrically.
Statistics
Data were analyzed using the JMP 4.0 and SAS 6.12 computer software packages (SAS Institute, Cary, NC).
| |
Results |
|---|
|
|
|---|
Lung Fibroblasts Increase Expression of SP mRNAs
Our initial experiments compared lung fibroblasts from
three different sources
embryonic rat lung, adult rat lung,
and adult human lung
for their ability to maintain SP
mRNA expression. As shown in Figure 1, coculture of
type II cells with any of the three of the fibroblast lines resulted in a marked increase in the relative abundance of
mRNAs for SP-A, SP-B, SP-C, and SP-D. Because the efficacy of the different fibroblasts appeared essentially equivalent, the remainder of the experiments were done using
the HLF.
|
We next determined the number of HLF required to elicit the observed response. Rafts containing 1 × 104 HLF gave no response above that seen in cells cultured alone or with a bare nucleopore filter (Figure 2). Rafts containing 1 × 105 HLF elicited an apparent small increase in the amount of all four SP mRNAs, but these increases reached statistical significance only for SP-A and SP-B (Table 1). Significant increases in all of the SP mRNAs (SP-A mRNA: 15-fold; SP-B mRNA: 8-fold; SP-C mRNA: 3- to 4-fold; SP-D mRNA: 4- to 5-fold) were seen when type II cells were cocultured with 1 × 106 HLF. Increasing the number of HLF to 2 and 3 × 106 cells per raft, however, had no further beneficial effect on SP gene expression (data not shown).
|
|
We then examined the ability of type II cells cultured in the presence of HLF to translate and process SP mRNAs. Type II cells cultured for 72 h in the presence of HLF were labeled for 4 h with [35S]-methionine and [35S]-cysteine and harvested, and cell lysates were sequentially immunoprecipitated with specific antibodies against SP-A, SP-B, SP-C, and SP-D. The results are shown in Figure 3. Immunoprecipitated SP-A gave a single dominant band of molecular mass 32-34 kD, consistent with what has been described for forms of SP-A containing immature oligosaccharide (5). Immunoprecipitation with an antibody against mature bovine SP-B (antibody #28031) gave a pattern similar to that seen in cultured human fetal lung explants (11): precursor peptides with molecular masses of 42 and 25 kD, along with processed proteolipids at 8 and 12 kD. An antibody against amino acids 1-20 of human pro-SP-C (antibody #68514) precipitated a 22-kD band of rat pro-SP-C, as well as its processing intermediates (12). Immunoprecipitation with antirat SP-D gave a single band at approximately 43 kD. Thus, it appears that type II cells in this culture system not only accumulated SP mRNAs but also translated them and processed the resultant peptides through normal pathways. Because type II cells cultured on Matrigel form multicellular aggregates with their apical surfaces directed inward, it should be noted that the SPs immunoprecipitated in these experiments represent intracellular peptides as well as any radiolabeled proteins that may have been secreted into the lumina during the labeling period.
|
We estimated the percentage of type II cells in the aggregates that were positive for the different SPs by immunohistochemistry. As can be seen in Figure 4, most of the epithelial cells were positive for SP-A, SP-B, and SP-C. The presence of immunoreactive material in the aggregate lumina suggested that these proteins were being secreted.
|
DEX Affects SP Expression in Type II Cell-Lung Fibroblast Cocultures
We next examined the effects of soluble factors in the coculture system. We chose to test DEX (10
7 M) and cyclic
adenosine monophosphate (cAMP). DEX was chosen because glucocorticoids have been shown to affect the surfactant system in the developing and adult lung, both in
vivo and in vitro (13). We tested the effect of increasing
intracellular cAMP (via treatment with 10 µM FSK + 10 µM
IBMX) because it has been shown to affect both SP gene
expression and surfactant phospholipid biosynthesis (14).
In addition, we have previously observed that cAMP improved functional differentiation of adult rat type II cells
maintained in serum-free conditions (15). The results of
these experiments are shown in Figure 5 and Table 2.
|
|
DEX given by itself had no significant effect on the level of SP-A mRNA. However, DEX antagonized the effects of HLF on SP-A mRNA expression, reducing the stimulation from 13-fold to 6-fold. The effect of DEX on SP-B expression was quite dramatic. Addition of DEX alone to type II cell cultures caused no significant stimulation of SP-B mRNA levels. However, when DEX was added to type II cells cocultured with HLF, the level of SP-B mRNA was increased 15-fold over that seen in type II cells cultured in the absence of any additions. The level of SP-B mRNA expression in these cells was equivalent to that seen in freshly isolated rat type II cells. The effect of DEX on SP-C mRNA expression was similar to that seen for SP-A: DEX by itself had no significant effect on SP-C mRNA expression, and significantly antagonized the positive (3- to 4-fold increase) effects of HLF on SP-C expression. DEX treatment by itself had no significant effect on SP-D mRNA levels, and also had no effect on the stimulation of SP-D mRNA caused by coculture with HLF.
Type II cells treated with FSK/IBMX as a single addition to the medium showed no significant differences in their content of mRNAs for SP-A, SP-B, and SP-D (Figure 5 and Table 2). SP-C mRNA levels, however, were significantly increased by elevating intracellular cAMP. When added to type II cells cocultured with HLF, FSK/IBMX had no effect on the accumulation of mRNAs for SP-B, SP-C, and SP-D, but significantly antagonized the positive effects of HLF on the accumulation of SP-A mRNA, reducing HLF stimulation from 13- to 8-fold.
KGF Is a Mediator of Lung Fibroblast Effects on Type II Cells
A number of recent studies have suggested that KGF (FGF-7) may serve as a signaling molecule mediating interactions between lung mesenchyme and epithelium (6, 16). In a previous study (17) we demonstrated that KGF stimulated accumulation of mRNAs for SP-A and SP-B, but not SP-C, when given for the last 2 d of a 6-d culture period. In the present study we examined type II cells treated with KGF for 3 d, beginning 24 h after plating. The results of exposing type II cells to increasing amounts of KGF are shown in Figure 6 and Table 3. KGF stimulated increased expression of all four SP mRNAs at a concentration of 1 ng/ml. The stimulation of SP-A, SP-B, and SP-D mRNAs peaked at 10 ng/ml and remained level thereafter. SP-C mRNA levels also peaked at 10 ng/ml, but then significantly declined with further increases in KGF.
|
|
We then compared the effects of KGF (at 10 ng/ml) on SP gene expression with those obtained when type II cells were cocultured with HLF. The results are shown in Figure 5 and Table 2. In these experiments there was no significant difference between KGF and HLF in their ability to stimulate accumulation of mRNAs for SP-B, SP-C, and SP-D. KGF treatment also induced a significant (7-fold) stimulation in SP-A mRNA, but this was less than that seen with HLF (13-fold). The further addition of DEX to KGF-containing medium gave results identical to those seen when DEX was added to cocultures of type II cells and HLF; DEX augmented stimulation of SP-B mRNA, but antagonized the positive effects of KGF on SP-A and SP-C mRNAs. Addition of FSK/IBMX to KGF-containing medium had no effect on mRNA levels for SP-B, SP-C, and SP-D. SP-A mRNA levels appeared to be reduced, but these changes did not reach statistical significance.
The similarity in the responses of type II cells to HLF to that seen with KGF suggested that KGF, which is produced by lung fibroblasts (16), might be mediating the positive effects of HLF. To address this possibility, we performed experiments in which type II cells and HLF were cocultured in the presence of a neutralizing antibody against human KGF. Because of uncertainty about how long the antibody would retain activity in culture, the duration of the experimental treatment was reduced to 24 h. The results are shown in Figure 7 and Table 4. Treatment of type II cells with 1 ng/ml KGF resulted in a significant stimulation in the levels of all four SP mRNAs. Simultaneous incubation with anti-KGF antibody ablated the effects of exogenously added KGF in every case. Incubation with the antibody by itself had no effect on SP mRNA levels. Type II cells cocultured with HLF for 24 h showed significant increases in levels of SP-A and SP-B mRNAs, but no significant effect on SP-C and SP-D mRNAs. Addition of anti-KGF antibody to the cocultures neutralized the positive effects of HLF, but only partially: whereas SP-A and SP-B mRNA levels were significantly reduced compared with those seen in cocultures, they remained significantly elevated over those seen in type II cells cultured with no additions.
|
|
Lung Fibroblasts and KGF Increase Synthesis of Phospholipids in Cultured Type II Cells
Because surfactant is composed primarily of phospholipids, we next determined the effects of HLF on the ability of type II cells to incorporate radiolabeled acetate into lipids during the last 24 h of culture. Because the type II cells and HLF are physically separated in the coculture system, we were able to examine acetate incorporation in type II cells only. Because of the significant effects that KGF had on SP mRNA levels, we also examined acetate incorporation in type II cells treated with KGF. Finally, we determined the effects of adding DEX to HLF/type II cell cocultures, and to type II cells cultured with KGF. The results are shown in Table 5.
|
Normalized to micrograms of DNA, HLF elicited a 9- to 10-fold increase in the amount of acetate incorporated into phosopholipids, and a 2- to 3-fold increase in acetate incorporated into neutral lipids. This effect was mimicked by the substitution of KGF for HLF. The effects of HLF and KGF differed substantially, however, when DEX was added to the cultures. DEX by itself stimulated acetate incorporation into phospholipids 3- to 4-fold, but did not significantly affect incorporation into neutral lipids. When added to type II cell/HLF cocultures, DEX had a significant inhibitory effect on acetate incorporation into phospholipids, but no effect on neutral lipid synthesis. In contrast, DEX added in combination with KGF had a significant positive effect on acetate incorporation into phospholipids, but no apparent effect on neutral lipid synthesis.
We next examined the pattern of acetate incorporation into individual phospholipid species (Table 6). Normalized to cellular DNA, type II cells cocultured with HLF incorporated 10 times more acetate into PC, saturated PC (sat PC), and phosphatidylglycerol (PG) than type II cells cultured with no additions. These effects were essentially duplicated by adding KGF to type II cell cultures in place of HLF. Significant differences were observed, however, when DEX was added to the cultures. DEX added by itself to cultured type II cells caused a significant increase in the amount of acetate incorporated per microgram of DNA into PC (4-fold), sat PC (4-fold), and PG (6-fold). When added to type II cell/HLF cocultures, DEX significantly antagonized the positive effects of HLF on the incorporation of acetate into PC and sat PC, but appeared to increase acetate incorporation into PG, although this did not reach statistical significance. When compared with cultures treated with KGF alone, concomitant treatment with DEX and KGF did not significantly affect acetate incorporation into PC or sat PC. Synthesis of PG, however, was substantially increased, rising 32-fold above that seen in type II cells cultured in control medium.
|
| |
Discussion |
|---|
|
|
|---|
It has long been appreciated that pulmonary mesenchyme
is required for normal lung development. Diffusible signals produced by the embryonic mesenchyme have profound effects on the growth, patterning, and differentiation of the developing lung epithelium (for reviews, see 18).
The normal alveolar wall in the adult, however, contains
relatively few fibroblasts compared with the number seen
associated with the developing epithelium. Our present observations suggest an important role for fibroblasts in
the adult alveolus
that epithelial-fibroblast interactions
may also be required for the maintenance of type II cell
differentiation in the adult. Our data show that coculture
of adult type II cells with lung fibroblasts has a marked
positive effect on their differentiated function: mRNA levels for SP-A, SP-B, SP-C, and SP-D were all substantially increased; these mRNAs were translated and processed; and
surfactant phospholipid biosynthesis was elevated 10-fold. Because the epithelial cells and fibroblasts were not allowed to come into contact, this improved differentiation
was mediated by diffusible factors produced by the fibroblasts. Further, the improvement we observed in type II
cell differentiation is not transitory. Whereas the duration
of culture in the present experiments was 4 d, in other studies (Pan and colleagues, submitted) we have shown that
type II cells cocultured with HLF will maintain highly differentiated characteristics for at least 2 wk.
We have previously observed (2) that adult rat type II cells cultured in association with lethally irradiated fibroblasts on floating collagen gels incorporated a higher percentage of acetate into phospholipids, notably PC and sat PC, than cells cultured on tissue culture plastic or in association with fibroblasts on attached collagen gels. This culture system, although useful, had several disadvantages. The most obvious of these is that the fibroblasts and type II cells were intimately associated with each other, thus all analyses were necessarily done on the combined cell types. This has been eliminated in the present culture system, where the epithelial cells and fibroblasts are physically separated from one another. A second disadvantage of the floating feeder layer system was that the fibroblasts were growth-arrested with irradiation. Although this prevented them from overgrowing the type II cells, the fibroblasts eventually died, making long-term culture difficult. This problem has been circumvented in the present culture system, where the fibroblasts are left untreated.
Coculture of fibroblasts with adult type II cells has been done by other investigators. Mangum and associates (19) cocultured primary rat type II cells and early passage rat lung fibroblasts on opposite sides of a collagen-coated polycarbonate filter. The type II cells formed a tight monolayer, but the cells appeared ultrastructurally dedifferentiated. Adamson and Young (20) showed that type II cells cultured on an endothelial cell ECM coating the surface of a culture insert incorporated significantly more [3H]thymidine when fibroblasts were present in the lower culture chamber. This activity was neutralized by the addition of anti-KGF antibodies. Pasternack and coworkers (21) demonstrated that medium conditioned by low-passage adult lung fibroblasts stimulated a significant increase in thymidine incorporation by adult type II cells. In contrast to the studies of Adamson and Young, Pasternack and colleagues could not demonstrate that the increased proliferation was due to KGF. A common characteristic of these culture systems is that the type II cells assumed a more flattened, squamous cell shape, which we have previously shown is not conducive to maintenance of type II cell differentiation (4, 22). The Matrigel substratum used in the present study allowed the type II cells both to interact with a basement membrane and to assume their native cuboidal cell shape. We believe that these conditions are necessary for the cells to be competent to respond to soluble factors provided by HLF, or to those added to the medium.
Our data indicate that KGF, which is produced by lung fibroblasts, is a major mediator of the positive effects of HLF on type II cells. These observations are in agreement with those of Chelly and associates (23), who demonstrated that KGF stimulated expression of SP-A, SP-B, and SP-C in cultured fetal rat type II cells, as well as incorporation of choline and acetate into sat PC. These increases in choline and acetate incorporation were correlated with increases in choline phosphate cytidyltransferase (CPCT) and fatty-acid synthase (FAS) activities, respectively. Together these data suggested an important role for KGF in the maturation of the surfactant system during late development. Our results indicate that the requirement for KGF may extend beyond fetal lung development, and that adult type II cells require KGF to sustain maximum levels of differentiation.
As suggested by our antibody neutralization experiments, however, KGF may not be the only active molecule provided by HLF. In these studies the anti-KGF antibody was able to completely neutralize the effects of exogenous KGF at a concentration (1 ng/ml) that elicited a response equal to or greater than the effects of coculturing with HLF. When added to type II cell/HLF cocultures, however, the antibody was only partially effective: it reduced SP-A and SP-B mRNAs to levels that were both significantly less than in cocultures treated with vehicle, but the levels remained significantly greater than type II cells cultured by themselves. This suggests that HLF produce a factor(s) in addition to KGF that stimulates accumulation of SP-A and SP-B mRNAs. SP-C mRNA levels did not increase in type II cells cocultured with HLF during the 24-h time course of these experiments, thus the antibody had no measurable neutralizing effect. Addition of KGF, however, modestly increased SP-C mRNA expression, and this was neutralized by the anti-KGF antibody.
How KGF affects expression of SP-C has yet to be completely defined. In a previous study we observed that KGF had little effect on SP-C mRNA levels when given to type II cells that had been precultured for 4 d in medium with no additions except serum (17). In the present study, however, we observed a 4-fold increase in SP-C mRNA in response to 10 ng/ml KGF, with levels decreasing significantly at higher concentrations of KGF; this biphasic dose effect was also observed by Chelly and coworkers (23) using fetal rat type II cells. Our present observations are in agreement with those in a previous report (6), in which type II cells were cultured at an air-liquid interface. In these earlier experiments KGF significantly increased SP-C mRNA levels, although not to the same extent we report here. Some insight into the results of Sugahara and colleagues (17) may be gained from results obtained in cultures of embryonic epithelium. KGF can sustain SP-C expression in embryonic distal lung epithelium when these rudiments are maintained in mesenchyme-free culture (24). However, we also observed (Shannon, unpublished observations) that embryonic lung epithelial rudiments became refractory to KGF stimulation when they were cultured in its absence for 48 h. Thus, it is possible that the lack of a KGF effect on SP-C mRNA levels observed in our earlier study was the result of withdrawing KGF stimulation for 96 h. The observation that SP-A and SP-B mRNAs were stimulated in that study (17) whereas SP-C mRNA was unaffected or inhibited illustrates the independent regulation of expression of all the SP genes.
KGF has myriad effects on pulmonary epithelial cells.
Prenatally, KGF stimulates proliferation and differentiation of the presumptive distal lung epithelium in culture
(24). KGF is necessary, but insufficient by itself, to effect
transdifferentiation of embryonic tracheal epithelium to
express a distal lung phenotype (25). The concentration of
KGF to which the epithelial cells are exposed is clearly important, however, because targeted overexpression of KGF
leads to developmental malformations consistent with pulmonary cystadenoma (26). Treatment of fetal lung explants in vitro with KGF results in cystic dilation of the epithelium (27), which results from epithelial fluid secretion
driven by cystic fibrosis transmembrane conductance regulator-independent Cl
transport (28).
The lung epithelial hyperplasia in the studies cited earlier results from pharmacologic levels of KGF. The question arises as to the role of KGF in the normal lung. The
adult lung contains levels of KGF mRNA equivalent to
those seen in skin (29), yet lung epithelial proliferation under normal conditions is comparatively low. KGF in the
normal lung may be sequestered by binding to heparan sulfate proteoglycan in the ECM and thus might not become bioactive until released. Our data, however, suggest
that KGF may play a nonmitogenic role in the adult lung
that of maintaining type II cell differentiation. The role of
KGF as a differentiation factor is supported by its ability
to specify the distal lung epithelial phenotype in embryonic respiratory epithelium (25). If KGF is involved in
maintenance of adult type II cell differentiation, however,
its absence can be compensated for by other FGFs, because mice null for KGF have no lung phenotype (30).
The ability of glucocorticoids to accelerate maturation of the surfactant system in the developing lung has been documented in numerous studies (13), but less is known about their effects on the surfactant system in the adult lung. Young and Silbajoris (31) demonstrated that treatment of adult rats with DEX for 1 wk resulted in 2- to 4-fold increases in total phospholipid and sat PC. Betamethasone administered to adult rats has been shown to upregulate CPCT, the rate-regulatory enzyme for PC synthesis (32). In our cultures, DEX treatment by itself significantly stimulated overall acetate incorporation into phospholipids, which is probably due to enhanced expression of FAS. Xu and Rooney (33) have shown that DEX increases FAS transcription and mRNA stability in explants of fetal rat lung, with a resultant increase in FAS mass and activity. When DEX was given in conjunction with KGF to our cultures, the effect was additive, which implies that DEX and KGF increase FAS activity by different mechanisms. In contrast, when given in conjunction with HLF, DEX significantly reduced acetate incorporation into phospholipids.
When individual phospholipid species were examined, DEX significantly stimulated acetate incorporation into PC, sat PC, and PG. DEX antagonized the positive effects of HLF on PC synthesis, but had no effect on sat PC or PG. DEX did not significantly alter the effects of KGF on PC and sat PC synthesis, but had a superadditive effect on PG synthesis. The different responses of type II cells to DEX when given in combination with KGF or HLF cells support the idea that HLF produce a bioactive factor(s) in addition to KGF. These data also underscore the complexity and independent regulation of individual surfactant phospholipids.
In summary, we have demonstrated that adult lung fibroblasts exert a decided positive influence on primary cultures of adult type II cells. These effects are mediated in part by KGF, but other as-yet-unidentified factors also play a positive role. The type II cell aggregates formed in this culture system do not easily allow the measurement of secretion. However, combining the strategies described in this study with other variations in culture conditions, such as maintaining the cells at an air-liquid interface, where cell apices are exposed to the medium (6, 34), may lead to a culture system in which regulation of the synthesis and secretion of surfactant components can be studied in long-term primary culture. These possibilities are currently under investigation.
| |
Footnotes |
|---|
Address correspondence to: John M. Shannon, Ph.D., Div. of Pulmonary Biology, Children's Hospital Medical Center, 3333 Burnet Ave., Cincinnati, OH 45229-3039. E-mail: john.shannon{at}chmcc.org
(Received in original form July 19, 2000 and in revised form October 31, 2000).
Acknowledgments: These studies were performed in the Lord and Taylor Laboratory for Lung Biochemistry and the Anna Perahia Adatto Clinical Research Center. This work was supported by National Heart, Lung, and Blood Institute Specialized Center for Research Grant HL-56556.
Abbreviations base pairs, bp; cyclic adenosine monophosphate, cAMP; complementary DNA, cDNA; counts/min, cpm; dexamethasone, DEX; Dulbecco's modified Eagle's medium, DMEM; fatty-acid synthase, FAS; fibroblast growth factor, FGF; forskolin, FSK; human lung fibroblasts, HLF; 3-isobutyl-1-methylxanthine, IBMX; keratinocyte growth factor, KGF; messenger RNA, mRNA; phosphate-buffered saline, PBS; phosphatidylcholine, PC; phosphatidylglycerol, PG; ribonuclease protection assay, RPA; ribosomal RNA, rRNA; saturated PC, sat PC; surfactant protein, SP.
| |
References |
|---|
|
|
|---|
1.
Paine, R. III, and
R. H. Simon.
1996.
Expanding the frontiers of lung biology through the creative use of alveolar epithelial cells in culture.
Am. J. Physiol.
270:
L484-L486
2. Shannon, J. M., R. J. Mason, and S. D. Jennings. 1987. Functional differentiation of alveolar type II epithelial cells in vitro: effects of cell shape, cell-matrix interactions, and cell-cell interactions. Biochim. Biophys. Acta 931: 143-156 [Medline].
3. Shannon, J. M., P. A. Emrie, J. H. Fisher, Y. Kuroki, S. D. Jennings, and R. J. Mason. 1990. Effect of a reconstituted basement membrane on expression of surfactant apoproteins in cultured adult rat alveolar type II cells. Am. J. Respir. Cell Mol. Biol. 2: 183-192 .
4.
Shannon, J. M.,
S. D. Jennings, and
L. D. Nielsen.
1992.
Modulation of alveolar type II cell differentiated function in vitro.
Am. J. Physiol.
262:
L427-L436
5.
Osanai, K.,
R. J. Mason, and
D. R. Voelker.
1998.
Trafficking of newly synthesized surfactant protein A in isolated rat alveolar type II cells.
Am. J. Respir. Cell Mol. Biol.
19:
929-935
6.
Xu, X.,
K. McCormick-Shannon,
D. R. Voelker, and
R. J. Mason.
1998.
KGF increases SP-A and SP-D mRNA levels and secretion in cultured rat
alveolar type II cells.
Am. J. Respir. Cell Mol. Biol.
18:
168-178
7. Dobbs, L. G., E. F. Geppert, M. C. Williams, R. D. Greenleaf, and R. J. Mason. 1980. Metabolic properties and ultrastructure of alveolar type II cells isolated with elastase. Biochim. Biophys. Acta 618: 510-523 [Medline].
8. Yoshizato, K., S. Kikuyama, and N. Shioya. 1980. Stimulation of glucose utilization and lactate production in cultured human fibroblasts by thyroid hormone. Biochim. Biophys. Acta 627: 23-29 [Medline].
9.
O'Reilly, M. A.,
A. F. Gazdar,
J. C. Clark,
T. J. Pilot-Matias,
S. E. Wert,
W. M. Hull, and
J. A. Whitsett.
1989.
Glucocorticoids regulate surfactant
protein synthesis in a pulmonary adenocarcinoma cell line.
Am. J. Physiol.
257:
L385-L392
10. Mason, R. J., and J. Nellenbogen. 1984. Synthesis of saturated phosphatidylcholine and phosphatidylglycerol by freshly isolated rat alveolar type II cells. Biochim. Biophys. Acta 794: 392-402 [Medline].
11.
Whitsett, J.,
T. Weaver,
J. Clark,
N. Sawtell,
S. Glasser,
T. Korfhagen, and
W. Hull.
1987.
Glucocorticoid enhances surfactant proteolipid Phe and
pVal synthesis and RNA in fetal lung.
J. Biol. Chem
262:
15618-15623
12.
Vorbroker, D. K.,
W. F. Voorhout,
T. E. Weaver, and
J. A. Whitsett.
1995.
Posttranslational processing of surfactant protein C in rat type II cells.
Am. J. Physiol.
269:
L727-L733
13.
Ballard, P. L..
1989.
Hormonal regulation of pulmonary surfactant.
Endocr.
Rev.
10:
165-181
14. Mendelson, C. R., and V. Boggaram. 1991. Hormonal control of the surfactant system in fetal lung. Annu. Rev. Physiol. 53: 415-440 [Medline].
15. Kawada, H., J. M. Shannon, and R. J. Mason. 1988. Improved maintenance of adult rat alveolar type II cell differentiation in vitro: effect of hydrocortisone and cyclic AMP. Biochim. Biophys. Acta 972: 152-166 [Medline].
16. Mason, I. J., F. Fuller-Pace, R. Smith, and C. Dickson. 1994. FGF-7 (keratinocyte growth factor) expression during mouse development suggests roles in myogenesis, forebrain regionalisation and epithelial-mesenchymal interactions. Mech. Dev. 45: 15-30 [Medline].
17.
Sugahara, K.,
J. S. Rubin,
R. J. Mason,
E. L. Aronsen, and
J. M. Shannon.
1995.
Keratinocyte growth factor increases mRNAs for SP-A and SP-B in
rat alveolar type II cells in culture.
Am. J. Physiol.
269:
L344-L350
18. Shannon, J. M., and R. R. Deterding. 1997. Epithelial-mesenchymal interactions in lung development. In Lung Growth and Development. J. A. McDonald, editor. Marcel Dekker, New York. 81-118.
19. Mangum, J. B., J. I. Everitt, J. C. Bonner, L. R. Moore, and A. R. Brody. 1990. Co-culture of primary pulmonary cells to model alveolar injury and translocation of proteins. In Vitro Cell. Dev. Biol. 26: 1135-1143 [Medline].
20.
Adamson, I. Y., and
L. Young.
1996.
Alveolar type II cell growth on a pulmonary endothelial extracellular matrix.
Am. J. Physiol.
270:
L1017-L1022
21.
Pasternack, M. Jr.,
X. Liu,
R. A. Goodman, and
D. E. Rannels.
1997.
Regulated stimulation of epithelial cell DNA synthesis by fibroblast-derived
mediators.
Am. J. Physiol
272:
L619-L630
22.
Shannon, J. M.,
T. Pan,
K. E. Edeen, and
L. D. Nielsen.
1998.
Influence of
the cytoskeleton on surfactant protein gene expression in cultured rat alveolar type II cells.
Am. J. Physiol.
274:
L87-L96
23.
Chelly, N.,
O. B. Mouhieddine-Gueddiche,
A. M. Barlier-Mur,
B. Chailley-Heu, and
J. R. Bourbon.
1999.
Keratinocyte growth factor enhances maturation of fetal rat lung type II cells.
Am. J. Respir. Cell Mol. Biol.
20:
423-432
24.
Deterding, R. R.,
C. R. Jacoby, and
J. M. Shannon.
1996.
Acidic fibroblast
growth factor and keratinocyte growth factor stimulate fetal rat pulmonary epithelial growth.
Am. J. Physiol.
271:
L495-L505
25. Shannon, J. M., S. A. Gebb, and L. D. Nielsen. 1999. Induction of alveolar type II cell differentiation in embryonic tracheal epithelium in mesenchyme-free culture. Development 126: 1675-1688 [Abstract].
26.
Simonet, W. S.,
M. L. DeRose,
N. Bucay,
H. Q. Nguyen,
S. E. Wert,
L. Zhou,
T. R. Ulich,
A. Thomason,
D. M. Danilenko, and
J. A. Whitsett.
1995.
Pulmonary malformation in transgenic mice expressing human keratinocyte growth factor in the lung.
Proc. Natl. Acad. Sci. USA
92:
12461-12465
27. Shiratori, M., E. Oshika, L. P. Ung, G. Singh, H. Shinozuka, D. Warburton, G. Michalopoulos, and S. L. Katyal. 1996. Keratinocyte growth factor and embryonic rat lung morphogenesis. Am. J. Respir. Cell Mol. Biol. 15: 328-338 [Abstract].
28.
Zhou, L.,
R. W. Graeff,
P. B. McCray Jr.,
W. S. Simonet, and
J. A. Whitsett.
1996.
Keratinocyte growth factor stimulates CFTR-independent fluid
secretion in the fetal lung in vitro.
Am. J. Physiol.
271:
L987-L994
29. Ulich, T. R., E. S. Yi, K. Longmuir, S. Yin, R. Bilta, C. F. Morris, R. M. Housley, and G. F. Pierce. 1994. Keratinocyte growth factor is a growth factor for type II pneumocytes in vivo. J. Clin. Invest. 93: 1298-1306 .
30.
Guo, L.,
L. Degenstein, and
E. Fuchs.
1996.
Keratinocyte growth factor is
required for hair development but not for wound healing.
Genes Dev.
10:
165-175
31.
Young, S. L., and
R. Silbajoris.
1986.
Dexamethasone increases adult rat
lung surfactant lipids.
J. Appl. Physiol.
60:
1665-1672
32. Mallampalli, R. K., S. N. Mathur, L. J. Warnock, R. G. Salome, G. W. Hunninghake, and F. J. Field. 1996. Betamethasone modulation of sphingomyelin hydrolysis up-regulates CTP:cholinephosphate cytidylyltransferase activity in adult rat lung. Biochem. J. 318: 333-341 .
33.
Xu, Z. X., and
S. A. Rooney.
1997.
Glucocorticoids increase fatty-acid synthase mRNA stability in fetal rat lung.
Am. J. Physiol.
272:
L860-L864
34.
Dobbs, L. G.,
M. S. Pian,
M. Maglio,
S. Dumars, and
L. Allen.
1997.
Maintenance of the differentiated type II cell phenotype by culture with an apical
air surface.
Am. J. Physiol.
273:
L347-L354
This article has been cited by other articles:
![]() |
M.-L. Franco-Montoya, J. R. Bourbon, X. Durrmeyer, S. Lorotte, P.-H. Jarreau, and C. Delacourt Pulmonary effects of keratinocyte growth factor in newborn rats exposed to hyperoxia Am J Physiol Lung Cell Mol Physiol, November 1, 2009; 297(5): L965 - L976. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Dasgupta, R. Sakurai, Y. Wang, P. Guo, N. Ambalavanan, J. S. Torday, and V. K. Rehan Hyperoxia-induced neonatal rat lung injury involves activation of TGF-{beta} and Wnt signaling and is protected by rosiglitazone Am J Physiol Lung Cell Mol Physiol, June 1, 2009; 296(6): L1031 - L1041. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Newman, E. Walsh, K. B. C. Apparao, and P. L. Sannes Fibroblast growth factor-binding protein and N-deacetylase/N-sulfotransferase-1 expression in type II cells is modulated by heparin and extracellular matrix Am J Physiol Lung Cell Mol Physiol, November 1, 2007; 293(5): L1314 - L1320. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Mondrinos, S. Koutzaki, P. I. Lelkes, and C. M. Finck A tissue-engineered model of fetal distal lung tissue Am J Physiol Lung Cell Mol Physiol, September 1, 2007; 293(3): L639 - L650. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wang, K. Edeen, R. Manzer, Y. Chang, S. Wang, X. Chen, C.J. Funk, G. P. Cosgrove, X. Fang, and R. J. Mason Differentiated Human Alveolar Epithelial Cells and Reversibility of their Phenotype In Vitro Am. J. Respir. Cell Mol. Biol., June 1, 2007; 36(6): 661 - 668. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Deimling, K. Thompson, I. Tseu, J. Wang, R. Keijzer, A. K. Tanswell, and M. Post Mesenchymal maintenance of distal epithelial cell phenotype during late fetal lung development Am J Physiol Lung Cell Mol Physiol, March 1, 2007; 292(3): L725 - L741. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Leiner, D. Newman, C.-M. Li, E. Walsh, J. Khosla, and P. L. Sannes Heparin and Fibroblast Growth Factors Affect Surfactant Protein Gene Expression in Type II Cells Am. J. Respir. Cell Mol. Biol., November 1, 2006; 35(5): 611 - 618. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Chen, B. A. Hyatt, M. L. Mucenski, R. J. Mason, and J. M. Shannon Identification and characterization of a lysophosphatidylcholine acyltransferase in alveolar type II cells PNAS, August 1, 2006; 103(31): 11724 - 11729. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nishina, F. Zhang, L. D. Nielsen, K. Edeen, J. Wang, and R. J. Mason Expression of CINC-2{beta} Is Related to the State of Differentiation of Alveolar Epithelial Cells Am. J. Respir. Cell Mol. Biol., November 1, 2005; 33(5): 505 - 512. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Lee, R. F. Gonzalez, C. J. Chapin, J. Busch, J. R. Fineman, and J. A. Gutierrez Nitric oxide decreases surfactant protein gene expression in primary cultures of type II pneumocytes Am J Physiol Lung Cell Mol Physiol, May 1, 2005; 288(5): L950 - L957. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Raoul, B. Chailley-Heu, A.-M. Barlier-Mur, C. Delacourt, B. Maitre, and J. R. Bourbon Effects of vascular endothelial growth factor on isolated fetal alveolar type II cells Am J Physiol Lung Cell Mol Physiol, June 1, 2004; 286(6): L1293 - L1301. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Zhang, T. Pan, L. D. Nielsen, and R. J. Mason Lipogenesis in Fetal Rat Lung: Importance of C/EBP{alpha}, SREBP-1c, and Stearoyl-CoA Desaturase Am. J. Respir. Cell Mol. Biol., February 1, 2004; 30(2): 174 - 183. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-M. Barlier-Mur, B. Chailley-Heu, C. Pinteur, A. Henrion-Caude, C. Delacourt, and J. R. Bourbon Maturational Factors Modulate Transcription Factors CCAAT/Enhancer-Binding Proteins {alpha}, {beta}, {delta}, and Peroxisome Proliferator-Activated Receptor-{gamma} in Fetal Rat Lung Epithelial Cells Am. J. Respir. Cell Mol. Biol., November 1, 2003; 29(5): 620 - 626. [Abstract] [Full Text] |
||||
![]() |
B. E. Isakson, G. J. Seedorf, R. L. Lubman, W. H. Evans, and S. Boitano Cell-Cell Communication in Heterocellular Cultures of Alveolar Epithelial Cells Am. J. Respir. Cell Mol. Biol., November 1, 2003; 29(5): 552 - 561. [Abstract] [Full Text] |
||||
![]() |
F. Zhang, W. Pao, S. M. Umphress, S. B. Jakowlew, A. M. Meyer, L. D. Dwyer-Nield, L. D. Nielsen, K. Takeda, E. W. Gelfand, J. H. Fisher, et al. Serum Levels of Surfactant Protein D Are Increased in Mice with Lung Tumors Cancer Res., September 15, 2003; 63(18): 5889 - 5894. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Roper, R. J. Staversky, J. N. Finkelstein, P. C. Keng, and M. A. O'Reilly Identification and isolation of mouse type II cells on the basis of intrinsic expression of enhanced green fluorescent protein Am J Physiol Lung Cell Mol Physiol, September 1, 2003; 285(3): L691 - L700. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Fehrenbach, C. Bube, J. M. Hohlfeld, P. Stevens, T. Tschernig, H. G. Hoymann, N. Krug, and H. Fehrenbach Surfactant Homeostasis Is Maintained In Vivo during Keratinocyte Growth Factor-induced Rat Lung Type II Cell Hyperplasia Am. J. Respir. Crit. Care Med., May 1, 2003; 167(9): 1264 - 1270. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Koval Sharing signals: connecting lung epithelial cells with gap junction channels Am J Physiol Lung Cell Mol Physiol, November 1, 2002; 283(5): L875 - L893. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. R. Rice, J. J. Conkright, C.-L. Na, M. Ikegami, J. M. Shannon, and T. E. Weaver Maintenance of the mouse type II cell phenotype in vitro Am J Physiol Lung Cell Mol Physiol, August 1, 2002; 283(2): L256 - L264. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. B. Ware and M. A. Matthay Keratinocyte and hepatocyte growth factors in the lung: roles in lung development, inflammation, and repair Am J Physiol Lung Cell Mol Physiol, May 1, 2002; 282(5): L924 - L940. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Bates, L. W. Gonzales, J.-Q. Tao, P. Rueckert, P. L. Ballard, and A. B. Fisher Recovery of rat type II cell surfactant components during primary cell culture Am J Physiol Lung Cell Mol Physiol, February 1, 2002; 282(2): L267 - L276. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Crit. Care Med. |